Seigo Akari Selected Research

Xanthine Dehydrogenase

4/2022	Plasma xanthine oxidoreductase is associated with carotid atherosclerosis in stable kidney transplant recipients.
1/2022	Xanthine oxidoreductase activity in marathon runners: potential implications for marathon-induced acute kidney injury.
1/2022	Possible role of insulin resistance in activation of plasma xanthine oxidoreductase in health check-up examinees.
9/2021	Independent association of plasma xanthine oxidoreductase activity with hypertension in nondiabetic subjects not using medication.
5/2021	Greater coronary lipid core plaque assessed by near-infrared spectroscopy intravascular ultrasound in patients with elevated xanthine oxidoreductase: a mechanistic insight.
1/2021	Association between plasma xanthine oxidoreductase activity and in-hospital outcomes in patients with stable coronary artery disease after percutaneous coronary intervention.
1/2021	Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seigo Akari Research Topics

Disease

2	Insulin Resistance 01/2022 - 09/2021
2	Hyperuricemia 01/2022 - 09/2021
2	Obesity 09/2021 - 01/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2021 - 01/2021
1	Carotid Artery Diseases 04/2022
1	Gout 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Liver Diseases (Liver Disease) 09/2021
1	Dyslipidemias (Dyslipidemia) 09/2021
1	Hypertension (High Blood Pressure) 09/2021
1	Diabetes Mellitus 08/2021
1	Hyperemia 05/2021
1	Inflammation (Inflammations) 05/2021
1	Weight Gain 01/2021
1	Overweight 01/2021
1	Atherosclerosis 01/2021
1	Neointima 01/2021
1	Body Weight (Weight, Body) 01/2021

Drug/Important Bio-Agent (IBA)

7	Xanthine DehydrogenaseIBA 04/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	FYX-051IBA 01/2021 - 01/2021
1	Uric Acid (Urate)IBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2021
1	Transaminases (Aminotransferases)IBA 08/2021
1	LipidsIBA 05/2021
1	C-Reactive ProteinIBA 05/2021
1	EnzymesIBA 05/2021
1	purineIBA 05/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021

Therapy/Procedure

2	Percutaneous Coronary Intervention 05/2021 - 01/2021
1	Glycemic Control 08/2021